HC Deb 09 May 1960 vol 623 c3W
Mr. Edelman

asked the Minister of Health which United States firms with subsidiary companies in Great Britain are at present being charged before the Senate Anti-Monopoly Sub-Committee with having created public hardship by the monopolist control of pharmaceutical prices for Salk vaccine; and what inquiry he has made into the incidence of comparable practices by these firms in this country.

Mr. Walker-Smith

So far as I am aware, no charges relating specifically to the price of Salk vaccine have been made before the Senate Sub-Committee on Anti-Trust and Monopoly. Five manufacturers of Salk vaccine were recently charged with price fixing by the Federal Government in the courts but I understand that the charge was dismissed.